Family Smoking Prevention and Tobacco Control Act

Family Smoking Prevention and Tobacco Control Act is a landmark United States federal law that granted the Food and Drug Administration unprecedented authority to regulate the manufacturing, marketing, and distribution of tobacco products. Signed into law by President Barack Obama on June 22, 2009, it represented the culmination of decades of public health advocacy following failed attempts at comprehensive regulation. The act aimed to reduce tobacco use among youth and provide consumers with better information about the dangers of products from companies like Philip Morris International and R.J. Reynolds.

Background and legislative history

The push for federal regulation of tobacco gained significant momentum following the 1998 Master Settlement Agreement between state attorneys general and major tobacco companies. Prior legislative efforts, such as those championed by Senator John McCain, had failed in the late 1990s. A pivotal legal setback occurred in 2000 when the Supreme Court of the United States ruled in FDA v. Brown & Williamson Tobacco Corp. that the Food and Drug Administration lacked congressional authority to regulate tobacco under the existing Federal Food, Drug, and Cosmetic Act. This decision created a clear need for new legislation, which was ardently pursued by public health groups like the American Cancer Society and key lawmakers including Representative Henry Waxman and Senator Ted Kennedy.

Key provisions

The act granted the Food and Drug Administration the power to restrict tobacco marketing, particularly to youth, leading to a ban on candy-flavored cigarettes and the use of terms like "light" or "low-tar." It required larger, graphic health warnings on packaging and mandated the disclosure of product ingredients to the Centers for Disease Control and Prevention. The law also gave the agency authority to regulate product standards, such as limiting nicotine levels, though not to zero, and required pre-market review for any new tobacco product. A significant provision prohibited Food and Drug Administration officials with ties to the tobacco industry from working on related regulations.

Implementation and regulatory impact

The Food and Drug Administration established the Center for Tobacco Products to oversee the new regulatory framework. Early actions included banning flavored cigarettes, enforcing age verification for sales, and launching public education campaigns like "The Real Cost." The agency issued deeming regulations in 2016 to extend its authority to electronic cigarettes, cigars, and other products like hookah tobacco. This move subjected manufacturers such as Juul Labs to pre-market authorization requirements and triggered significant industry pushback, particularly from the vaping sector and cigar manufacturers in states like Florida.

Legal challenges and Supreme Court rulings

The law's constitutionality was immediately challenged by tobacco companies including Lorillard Tobacco Company and R.J. Reynolds. In 2012, the United States Court of Appeals for the Sixth Circuit largely upheld the law in cases like Discount Tobacco City & Lottery, Inc. v. United States. A major subsequent legal battle centered on the act's application to electronic cigarettes, culminating in the 2010 ruling in Sottera, Inc. v. Food & Drug Administration by the United States Court of Appeals for the D.C. Circuit, which held that such products could be regulated as tobacco products if not marketed for therapeutic purposes. Further challenges have targeted graphic warning label mandates and flavor restrictions.

Public health effects and evaluation

Studies by the National Institutes of Health and the Surgeon General of the United States have indicated the act contributed to a continued decline in youth smoking rates. The expansion of authority to electronic cigarettes created a complex public health landscape, with debates focusing on harm reduction for adult smokers versus potential youth initiation. Organizations like the Campaign for Tobacco-Free Kids have advocated for stronger measures, including a ban on menthol cigarettes, which the Food and Drug Administration has pursued. Evaluations suggest the law fundamentally altered the regulatory environment for one of the nation's leading causes of preventable death, attributed to diseases like lung cancer and emphysema.

Category:United States federal health legislation Category:2009 in American law Category:Food and Drug Administration